Fulvotomentoside A
Fulvotomentoside A ameliorates intestinal inflammation by modulating key immune mediators, significantly reducing IL-6 and IL-17A overexpression while upregulating the regulatory T-cell transcription factor Foxp3. This small molecule is a valuable research tool for investigating inflammatory bowel disease mechanisms in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
150107-44-1
Product Name Alternative
Fulvotomentoside A
Purity
99.59% (May vary between batches)
Solubility
DMSO:12.08 mg/mL (10.01 mM)
Smiles
C (O[C@@H]1O[C@H] (CO[C@@H]2O[C@H] (CO) [C@@H] (O) [C@H] (O) [C@H]2O) [C@@H] (O) [C@H] (O) [C@H]1O) (=O) [C@]34[C@] (C=5[C@@] (C) (CC3) [C@@]6 (C) [C@] (CC5) ([C@]7 (C) [C@@] (CC6) ([C@@] (CO) (C) [C@@H] (O[C@H]8[C@H] (O[C@H]9[C@H] (O) [C@H] (O[C@H]%10[C@H] (O) [C@@H] (O) [C@H] (O) CO%10) [C@@H] (O) [C@H] (C) O9) [C@@H] (O) [C@@H] (O) CO8) CC7) [H]) [H]) (CC (C) (C) CC4) [H]
Molecular Formula
C58H94O26
Molecular Weight
1207.35
Storage Conditions
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
